Activity sensors to evaluate the effect of sacubitril/valsartan on quality ‐of‐life in heart failure: rationale and design of the AWAKE‐HF study

ConclusionsThis will be the first study to assess the effects of sacubitril/valsartan on objective measures of sleep and activity in individuals with HFrEF within the context of their daily lives. Wearable accelerometer devices will be used to gain insight into how the medication affects physical activity and sleep.

Source: ESC Heart Failure - October 21, 2019 Category: Cardiology Authors: Raj M. Khandwalla, Kade Birkeland, J. Thomas Heywood, Steven Steinhubl, Kevin McCague, Emmanuel Fombu, Daniel Grant, Jerome B. Riebman, Robert L. Owens Tags: Study Design Source Type: research